Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant - Priority Announcement: Institute of Gender and Health

McMaster University

$100,000.00

Dieldrin increases breast cancer metastasis via dysregulation of neurotrophin expression.

FY 2008-09

Summary
Exposure to biohazardous environmental toxicants is linked with an increased risk for breast cancer. While the biomedical literature supporting this relationship is inconclusive, animal studies and tissue culture experiments provide evidence for the biological plausibility. However, the mechanisms are poorly understood and suitable animal models are limited. To elucidate the mechanisms of environmental toxicants on breast cancer development and metastasis my laboratory uses a unique mouse model of breast cancer. Specifically this mouse model expresses the c-erbB2 gene and mimics many of the features of breast cancer including metastasis. Thus unlike conventional animal models, the model we use allows for testing on a background of risk that we think is more relevant to human health. We have shown that exposure to dieldrin, an estrogenic pesticide that is associated with a significant increased risk for breast cancer and decreased survival, dose dependently increased mammary tumour burden together with expression of Brain Derived Neurotrophic Factor (BDNF) and tyrosine kinase receptor B (Trk B), factors important in cancer cell survival and metastasis. Preliminary studies also reveal that dieldrin dose dependently increased cell invasion and survival as well as BDNF and Trk B expression in two human breast cancer cell lines (invasive and non-invasive). Therefore, we postulate that dieldrin exposure will increase breast cancer metastases via binding with the estrogen receptor and stimulation of BNDF expression and Trk B signalling resulting in increased cell invasion and metastasis. This study will provide insight into the mechanisms underlying the increased risk of breast cancer in women exposed to estrogenic chemicals. Since metastasis is associated with poor prognosis and death our results are expected to influence future testing strategies and regulatory approaches to estrogenic chemicals.
Program
Operating Grant - Priority Announcement: Institute of Gender and Health
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
176576
Name
Foster Warren G
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Gender and Health
Theme2
Biomedical
Prcname2
Pharmacology & Toxicology
Projecttitle
Dieldrin increases breast cancer metastasis via dysregulation of neurotrophin expression.
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Institute of Gender and Health
Keyworddelim
Apoptosis; Breast Cancer; Invasion; Metastasis; Neurotrophins; Toxicology
Abstract
Exposure to biohazardous environmental toxicants is linked with an increased risk for breast cancer. While the biomedical literature supporting this relationship is inconclusive, animal studies and tissue culture experiments provide evidence for the biological plausibility. However, the mechanisms are poorly understood and suitable animal models are limited. To elucidate the mechanisms of environmental toxicants on breast cancer development and metastasis my laboratory uses a unique mouse model of breast cancer. Specifically this mouse model expresses the c-erbB2 gene and mimics many of the features of breast cancer including metastasis. Thus unlike conventional animal models, the model we use allows for testing on a background of risk that we think is more relevant to human health. We have shown that exposure to dieldrin, an estrogenic pesticide that is associated with a significant increased risk for breast cancer and decreased survival, dose dependently increased mammary tumour burden together with expression of Brain Derived Neurotrophic Factor (BDNF) and tyrosine kinase receptor B (Trk B), factors important in cancer cell survival and metastasis. Preliminary studies also reveal that dieldrin dose dependently increased cell invasion and survival as well as BDNF and Trk B expression in two human breast cancer cell lines (invasive and non-invasive). Therefore, we postulate that dieldrin exposure will increase breast cancer metastases via binding with the estrogen receptor and stimulation of BNDF expression and Trk B signalling resulting in increased cell invasion and metastasis. This study will provide insight into the mechanisms underlying the increased risk of breast cancer in women exposed to estrogenic chemicals. Since metastasis is associated with poor prognosis and death our results are expected to influence future testing strategies and regulatory approaches to estrogenic chemicals.
Competitiondate
200809
Approvedterm2
1 yr 0 mth
Pinamesdelim
Foster, Warren G
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~